Gilead Sciences (GILD) Shares Issued (2009 - 2026)

Gilead Sciences has reported Shares Issued for 18 years, with the latest figure at $166.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued fell 34.13% year-over-year to $166.0 million; the trailing twelve-month figure through Mar 2026 stood at $322.0 million (down 39.02% YoY), and the FY2025 full-year result was $408.0 million, down 3.32% from the prior year.
• Shares Issued for Q1 2026 stood at $166.0 million, up from $32.0 million in the prior quarter.
• The five-year high for Shares Issued was $252.0 million in Q1 2025, with the low at $3.0 million in Q2 2022.
• Historically, Shares Issued has averaged $90.4 million across 5 years, with a median of $94.0 million in 2022.
• Annual changes were most pronounced in 2022 — Shares Issued soared 1366.67% — and 2023, when it tumbled 85.23%.
• Gilead Sciences' Shares Issued stood at $176.0 million in 2022, then plunged by 85.23% to $26.0 million in 2023, then jumped by 565.38% to $173.0 million in 2024, then plunged by 81.5% to $32.0 million in 2025, then soared by 418.75% to $166.0 million in 2026.
• The last three Shares Issued figures came in at $166.0 million (Q1 2026), $32.0 million (Q4 2025), and $97.0 million (Q3 2025), per Business Quant data.